A Cell-Free Biosensor for Assessment of Hyperhomocysteinemia.
Fernanda PiorinoShelbe JohnsonMark P StyczynskiPublished in: ACS synthetic biology (2023)
Hyperhomocysteinemia─a condition characterized by elevated levels of homocysteine in the blood─is associated with multiple health conditions including folate deficiency and birth defects, but there are no convenient, low-cost methods to measure homocysteine in plasma. A cell-free biosensor that harnesses the native homocysteine sensing machinery of Escherichia coli bacteria could satisfy the need for a detection platform with these characteristics. Here, we describe our efforts to engineer a cell-free biosensor for point-of-care, low-cost assessment of homocysteine status. This biosensor can detect physiologically relevant concentrations of homocysteine in plasma with a colorimetric output visible to the naked eye in under 1.5 h, making it a fast, convenient tool for point-of-use diagnosis and monitoring of hyperhomocysteinemia and related health conditions.
Keyphrases
- cell free
- low cost
- label free
- sensitive detection
- gold nanoparticles
- quantum dots
- escherichia coli
- circulating tumor
- healthcare
- public health
- mental health
- health information
- pregnant women
- high throughput
- human health
- health promotion
- climate change
- klebsiella pneumoniae
- fluorescent probe
- replacement therapy
- circulating tumor cells
- candida albicans